Zhu Chenting, Bilali Aishan, Georgieva Gabriela S, Kurata Shunichi, Mitaka Chieko, Imai Takasuke
Department of Critical Care Medicine, Biomedical Genetics, Medical Research Institute, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
Transl Res. 2008 Dec;152(6):273-82. doi: 10.1016/j.trsl.2008.10.008. Epub 2008 Nov 14.
Ischemia reperfusion (I/R) injury of the lung affects the function of the nonischemic lung. Our objective is to determine how apocynin, which is a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, protects the nonischemic control right lung (RL) from injury by the unilateral ischemic left lung (LL). In isolated ventilated (by air containing 5% CO(2)) rat lungs, in which differential perfusion of the RL or LL was feasible, the LL was selectively made ischemic (60 min) and reperfused (30 min) in a nonrecirculating or recirculating manner with buffer (Krebs-Henseleit) solution, or in a recirculating manner with buffer that contained apocynin (10 mmol/L) or apocynin + TACEI (tumor necrosis factor)-alpha converting enzyme inhibitor; 10 microg/mL) (each group: n = 12) or with buffer that contained SOD (superoxide dismutase, 3000 U before ischemia and at reperfusion) or SOD + TACEI (each group: n = 5). The permeability of pulmonary endothelium/epithelium (wet/dry ratio and protein content of bronchoalveolar lavage fluid of each lung), perfusion pressure, and cytokine messenger RNA (mRNA) expression was increased not only in the LL (compared with nonischemic control RL, P < 0.01 with paired-samples T) but also in the RL in recirculating groups (compared with RL in the nonrecirculating group). Apocynin + TACEI as well as SOD + TACEI prevented those permeability increases in the RL by the ischemic LL. However, apocynin with or without TACEI as well as SOD with or without TACEI could only partially ameliorate I/R injury in the LL (P < 0.01 by 1-way analysis of variance (ANOVA)). TNF-alpha and possibly reactive oxygen species produced and released from the ischemic lung may synergistically induce control RL (remote organ) damage.
肺缺血再灌注(I/R)损伤会影响非缺血肺的功能。我们的目的是确定作为烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶抑制剂的阿朴吗啡如何保护非缺血对照右肺(RL)免受单侧缺血左肺(LL)的损伤。在可实现RL或LL差异灌注的离体通气(含5%二氧化碳的空气)大鼠肺中,LL以非循环或循环方式用缓冲液(Krebs-Henseleit)溶液选择性缺血(60分钟)并再灌注(30分钟),或以循环方式用含阿朴吗啡(10 mmol/L)或阿朴吗啡+肿瘤坏死因子(TNF)-α转换酶抑制剂(10μg/mL)的缓冲液(每组:n = 12),或用含超氧化物歧化酶(SOD,缺血前和再灌注时3000 U)或SOD + TNF-α转换酶抑制剂的缓冲液(每组:n = 5)。肺内皮/上皮通透性(各肺支气管肺泡灌洗液的湿/干比和蛋白质含量)、灌注压力和细胞因子信使核糖核酸(mRNA)表达不仅在LL中增加(与非缺血对照RL相比,配对样本T检验P < 0.01),而且在循环组的RL中也增加(与非循环组的RL相比)。阿朴吗啡+ TNF-α转换酶抑制剂以及SOD + TNF-α转换酶抑制剂可防止缺血LL导致RL的通透性增加。然而,无论有无TNF-α转换酶抑制剂的阿朴吗啡以及无论有无TNF-α转换酶抑制剂的SOD只能部分改善LL中的I/R损伤(单因素方差分析(ANOVA)P < 0.01)。缺血肺产生和释放的TNF-α以及可能的活性氧可能协同诱导对照RL(远处器官)损伤。